Management Team
Thomas ("Kerry") McCarter, Chief Executive Officer Allan Staley, President Stephen K. E. Forden, Vice President, Sales & Marketing Michael Weber, Director, R&D / QA Guy G. Levy, Chief Science Officer and Co-Founder David E. Martin, PHD
CEO Thomas ("Kerry") McCarter joined Soluble Systems in August, 2005 as Chief Executive Officer. Mr. McCarter has a proven ability to lead growth in start-up companies and in difficult "turnaround" situations. As Managing Director/President/Regional VP of Johnson & Johnson Companies in Russia and Western Europe, Mr. McCarter restructured and introduced a number of businesses to improve both market share and profitability. As VP Marketing for Johnson & Johnson Hospital Services, he introduced industry leading marketing programs and expanded J&J participation in alternative healthcare markets. Currently, he is a member of the Board of Directors of MedSci Technologies; a urology focused medical device company. Prior to his 20 years with J&J, Mr. McCarter held management positions with Procter & Gamble and General Electric in marketing, manufacturing, and human resources and wrote for FORBES Magazine. He holds a BA in Economics from the Maxwell School of Syracuse University and a Masters in Business Administration (with Distinction) from Harvard Business School.
President Allan R. Staley co-founded Soluble Systems with his business partner, Dr. Guy G. Levy, in 1999 and became its President in January 2007. Over the last 10 years, Mr. Staley has used his creative skills to help Dr. Levy develop and refine the company's patented polymer technology into a line of commercially viable wound care products under the brand name of TheraGauze®. Mr. Staley is formerly a member of Patten, Wornom, Hatten & Diamonstein, L.C. and served on its Executive Committee after merging with the firm in 1999. Prior to 1999, Mr. Staley was the Managing Partner of Diamonstein & Staley. In his 20 years practicing business law, Mr. Staley closed nearly $1 Billion in acquisitions and financings. He is an 1982 honors graduate of Randolph-Macon College, with a BS in Economics and Business. Mr. Staley received his JD from the Marshall-Wythe School of Law at the College of William & Mary in 1986, with a summer term in Exeter, England.
Stephen is the newest member of the Soluble Systems management team. He is a highly experienced executive who has, over the past 20 years, successfully led global, country and multi-cultural teams. Stephen has held a number of management positions with Johnson & Johnson, Smith & Nephew, Zimmer and ConvaTec allowing him to gain strong financial and analytical skills through experiences in sales management, global/country marketing and divestiture/acquisition of corporate entities. He joins us directly from ConvaTec where he achieved sales and revenue targets for six consecutive years as the senior sales leader in both the US and Japan. Most recently, he held the role of VP, Sales and Marketing, Continence and Critical care where he was instrumental in integrating a new company (UnoMedical) into the ConvaTec family while maintaining ConvaTec’s market leadership in bowel management. Throughout his career, Stephen has consistently proven his ability to meet budgeted revenues, manage multi-faceted corporate change and successfully launch/market products both globally and in country. Stephen led the internal transition of company activities during the spin off of Zimmer from Bristol Myers Squibb resulting in successful Day One activities as a stand-alone public entity. He has also implemented major corporate change including re-organizations and consolidation/relocation of divisional headquarters. Stephen also successfully developed and launched products both globally and in country within the areas of Wound Management, Critical Care and Orthopedics. Stephen received his degree, Bachelor of Business Administration from Wilfrid Laurier University (Waterloo, Ontario, Canada) in 1986.
Mr. Weber has over 13 years' experience in pharmaceutical R&D and manufacturing at both branded and generic firms, most recently at Amgen Manufacturing and Pfizer Global Research.
He started his career as an analytical chemist, with research projects including food chemistry, laser spectroscopy, and separations using capillary electrophoresis and HPLC. As a QA professional, Mr. Weber brought newly formed labs into GMP compliance, led multi-site investigations for FDA Pre-Approval Inspection readiness, and developed many pilot programs for new projects. His particular areas of expertise include developing robust quality systems, auditing current systems and GMP compliance. He earned a B.S. in Chemistry from the University of Maryland in 1994.
Guy G. Levy co-founded Soluble Systems with his business partner, Allan R. Staley, in 1999. In 1997, Dr. Levy began a quest to improve the quality of life and oral health of his patients who suffered with xerstomia (dry mouth). This desire led to a patented break-through in polymer technology that today represents one of the most exciting advances in wound care--extended moisture delivery without maceration.
Dr. Levy earned a BS in Biology from Virginia Tech (Class of 1984 but completed course work in three years in 1983), a DDS with Honors from Georgetown University School of Dentistry in 1987 and a MS in Health Administration from the Medical College of Virginia at Virginia Commonwealth University in 1992. Dr. Levy has practiced general dentistry since 1987, now in Yorktown, Virginia, with an emphasis on laser and microscopic therapies.
David E. Martin, PHD joined the Soluble Systems team in December 2008 as Director of Innovation Strategy. David also serves as Executive Chairman of M·CAM, Inc., an international leader in intellectual property-based financial risk management. M·CAM has established a global standard in intangible asset-backed finance, innovation finance arbitrage for the public and private sector, technology proliferation and counter-proliferation tracking, and patent quality and commercial validity assessment and management.
As a former Assistant Professor at the University of Virginia's School of Medicine, Dr. Martin founded the University's first wholly-owned, for-profit, research and development, and technology-transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques in innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia's Center for Innovative Technology (CIT) on numerous occasions. Dr. Martin is also a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration.